APOE and coronary artery disorder: Of this sample, we excluded: n = 11 participants with missing APOE genotypes; n = 6,456 non-regular statin users with less than four prescriptions per year or residuals from the linear regression for total statin prescriptions on years of statin treatment greater than 3 or less than -3; n = 1,273 non-statin users diagnosed with CAD at baseline (or prior to baseline); n = 4,566 participants starting statin after a doctor’s diagnosis of coronary artery disease (CAD) based on the hospital admission records.